Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Non-Current Assets (2021 - 2025)

Bioadaptives' Non-Current Assets history spans 5 years, with the latest figure at $14000.0 for Q4 2025.

  • Quarterly results put Non-Current Assets at $14000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $46500.0 (up 158.33% YoY), and the annual figure for FY2025 was $14000.0, changed.
  • Non-Current Assets for Q4 2025 was $14000.0 at Bioadaptives, down from $15500.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $166625.0 in Q3 2023 to a low of $1644.0 in Q2 2023.
  • The 5-year median for Non-Current Assets is $16250.0 (2025), against an average of $36789.8.
  • The sharpest move saw Non-Current Assets crashed 96.38% in 2022, then skyrocketed 4435.25% in 2023.
  • Year by year, Non-Current Assets stood at $59709.0 in 2021, then crashed by 94.99% to $2990.0 in 2022, then skyrocketed by 416.42% to $15441.0 in 2023, then rose by 16.57% to $18000.0 in 2024, then fell by 22.22% to $14000.0 in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $14000.0, $15500.0, and $17000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.